8月27日,蓝丰生化生物化工股份有限公司公布2013年上半年业绩中报。报告显示,2013年1—6月,公司实现营业收入7.33亿元,比上年同期增长16.92%。受到国内经济持续低迷,安全环保形势严峻,农药市场无序竞争加剧等的影响,公司大吨位产品开工率不足,导致归属于上市公司股东的净利润出现下滑,为2769.17万元,比上年同期减少28.28%。 On August 27, Lanfeng Biochemical Biochemical Co., Ltd. released its 2013 first half results. The report shows that from January to June 2013, the company achieved operating income of 733 million yuan, an increase of 16.92% over the previous year. Affected by the continuous downturn of the domestic economy, grim safety and environmental protection and aggravating disorderly competition in the pesticide market, the operating profit of large-tonnage products of the Company was insufficient. As a result, the net profit attributable to shareholders of listed companies decreased by 27,691,700 yuan over the same period of previous year A decrease of 28.28%.